Dr. S Geetalakshmi, Consultant Endocrinologist, Pragathi Endocrine clinic and Dr Kamakshi memorial hospital, Chennai
The multisystem inflammatory syndrome is an unusual complication of COVID-19 infections seen in children who have recently got infected with the coronavirus. COVID-19 has triggered the new-onset of diabetes in children.
What is Multisystem Inflammatory syndrome?
Multisystem inflammatory syndrome in children (MIS-C) is a clinical condition characterized by the inflammation of different parts of the body, including the lungs, heart, kidneys, brain, gastrointestinal organs, skin, or eyes. The doctors are yet to know the exact cause for Multisystem inflammatory syndrome in children. However, many children developed
MIS-C after getting infected with the coronavirus. The MIS-C, if left untreated, can lead to severe or fatal consequences.
What are the symptoms of Multisystem Inflammatory Syndrome?
Children with MIS-C exhibit the following symptoms:
Pain in abdomen
Pain/ tightness in the chest
Pain in the neck
Low blood pressure levels
However, some children may exhibit different symptoms.
How is COVID-19 causing new-onset type1 diabetes in children with
multisystem inflammatory syndrome?
COVID-19 has affected everyone, and children are no exception. Earlier children did not show any severe complications associated with the coronavirus infection. But with frequent mutations of the coronavirus, children are also at risk to develop COVID-19 severe related complications.
With an increase in the number of children infected with coronavirus, doctors noted that many of the children who were previously infected with coronavirus developed type1 diabetes. Some doctors also reported that many children who developed type1 diabetes after getting infected with COVID-19 exhibited symptoms of Diabetic Ketoacidosis. Diabetic
ketoacidosis can affect kidneys, brains, and other organs. Sometimes diabetic ketoacidosis can alter the blood electrolyte levels. If left untreated diabetic ketoacidosis can cause fatal complications, especially in people with low blood insulin levels.
Researchers have found that the coronavirus destroys the Beta cells present in the pancreas. These Beta cells are responsible for the production of insulin. Therefore, any damage to the Beta cells directly affects the production of insulin. If there is reduced or no insulin production in the body, the blood sugar levels rise, leading to complications.
How to protect your child from COVID-19?
“Prevention is better than cure.”
Prevention is always better. Even the thought of your child getting infected
with COVID-19 might send chills to your spine. Thus, being a parent, you
must ensure your child’s safety against coronavirus by taking the following
Encourage frequent hand wash.
Disinfect frequently contacted surfaces regularly.
Ensure that your children are not physically in close contact with
Encourage your child to wear a mask when they go outside.
Wash soft toys regularly and disinfect the toys of your children
Avoid going out and stay indoors.
We know our children are the apple of our eyes. By taking the necessary
care and precaution, we can reduce the risk of getting infected with the
- India records less than 30,000 fresh COVID-19 cases in over three months - July 27, 2021
- Coronavirus lockdown and lack of sunlight: How Ayurveda helps in maintaining Vitamin D balance - July 27, 2021
- Pfizer, AstraZeneca vaccine antibody levels may decline after 2-3 months: Lancet study - July 27, 2021
- Govt trashes reports on missing target of administering 50 crore Covid vaccine doses by July-end - July 27, 2021
- Vitamin-C for fighting anxiety and depression - July 26, 2021
- Sun Pharma, Cassiopea SpA ink license & supply agreements for acne treatment drug Winlevi - July 26, 2021
- SpiceHealth launches mobile COVID-19 testing lab in Guwahati - July 26, 2021
- Smile Foundation’s “Health Cannot Wait Campaign” Aims to Provide 1 Million Protective Kits to Frontline Health Workers - July 26, 2021
- Vitiligo and the stigma associated with it - July 26, 2021
- Bharat Biotech terminates MoU with Brazilian partners after graft allegations - July 24, 2021